Search

everythinglearnresearchcommunity

for

Search:↓

Nanoencapsulation creates adjustable cell clusters for hair growth.

Some growth factors, while important for normal body functions, can cause diseases when not regulated properly.

Spermidine helps protect against aging by preserving telomere length.

Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.

Platelet-Rich Plasma (PRP) treatment can potentially increase hair density and quality in people with hair loss, but more research is needed to confirm its effectiveness.

Treat pattern hair loss with finasteride and topical minoxidil.

XIST RNA helps regenerate hair follicles by targeting miR-424 and activating hedgehog signaling.

Minoxidil detects nitrite in water, creating a simple, cheap test.

Exosomes from umbilical cord cells fix hearing loss and damaged ear hair cells in mice.

Betamethasone is more effective than Tacrolimus and soft paraffin for hair regrowth in patchy alopecia areata.

Surface-modified nanostructured lipid carriers can improve hair growth treatments.

Metal organic frameworks-based scaffolds show promise for tissue repair due to their unique properties.

Plant-based chemicals may help hair growth and prevent hair loss but need more research to compete with current treatments.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

The SGAP flap effectively treats large sacral pressure sores with good results and minimal complications.

Hair transplant surgeries can be improved by preserving follicles in a special solution, and surgeries done at outpatient facilities are more profitable than those at hospitals.

Outpatient aesthetic and reconstructive surgeries are about equally profitable in Academic Health Centers and Ambulatory Surgery Centers when time is considered, but dedicated surgery centers are generally more profitable.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

Researchers successfully isolated and identified key markers of stem cell-enriched human hair follicle bulge cells.

Chemotherapy affects blood vessels in hair follicles, not stem cells, allowing hair regrowth.

Immune cells in Hidradenitis suppurativa become more inflammatory and may be important for treatment targets.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

The enzyme RDH12 plays a role in vision and retinal disease, with mutations leading to early onset visual loss and blindness, but the exact disease mechanism is unclear and there are no treatments yet.

Hair follicle stem cells are promising for blood vessel formation and tissue repair.

A new hair loss treatment with two unique ingredients improved hair growth.